ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

BYOT Byotrol Plc

0.125
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.01P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.125 0.05 0.20 0.125 0.125 0.125 5,325,313 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 4.59M -1.69M -0.0037 -0.32 544.67k

Byotrol PLC Director Dealing (8450Y)

24/08/2018 12:01pm

UK Regulatory


Byotrol (LSE:BYOT)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Byotrol Charts.

TIDMBYOT

RNS Number : 8450Y

Byotrol PLC

24 August 2018

24 August 2018

Byotrol plc

("Byotrol", the "Company" or the "Group")

Director Dealing

Byotrol plc, the AIM listed anti-microbial technology company, is pleased to announce that on 24 August 2018, Dr Trevor Francis, Chief Technical Officer of the Company purchased 657,686 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 3.8p per Ordinary Share (the "Purchase").

Following the Purchase, Mr. Francis has an interest in 2,910,902 Ordinary Shares representing approximately 0.68 per cent. of the total voting rights of the Company.

Enquiries:

Enquiries:

   David Traynor - Chief Executive, Byotrol plc                          01925 742 000 
   David Paton - Investor Relations                                            07714 190 474 

finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)

Geoff Nash/Kate Bannatyne- Corporate Finance

Tim Redfern/Richard Chambers - Corporate Broking

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.

Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

For more information, please go to www.byotrol.co.uk

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 
      1.   Details of the person discharging managerial responsibilities 
            / person closely associated 
 a)        Name                             Trevor Francis 
          -------------------------------  ---------------------------------- 
      2.   Reason for the Notification 
          ------------------------------------------------------------------- 
 a)        Position/status                  Chief Technical Officer 
          -------------------------------  ---------------------------------- 
 b)        Initial notification/Amendment   Initial 
          -------------------------------  ---------------------------------- 
 3.        Details of the issuer, emission allowance market participant, 
            auction platform, auctioneer or auction monitor 
          ------------------------------------------------------------------- 
 a)        Name                             Byotrol Plc 
          -------------------------------  ---------------------------------- 
 b)        LEI                              213800AJMTSTIPA59A34 
          -------------------------------  ---------------------------------- 
 4.        Details of the transaction(s): section to be repeated 
            for (i) each type of instrument; (ii) each type of transaction; 
            (iii) each date; and (iv) each place where transactions 
            have been conducted 
          ------------------------------------------------------------------- 
 a)        Description of the               ordinary shares of 0.25p each 
            Financial instrument, 
            type of instrument 
           Identification code              GB00B0999995 
          -------------------------------  ---------------------------------- 
 b)        Nature of the transaction        Purchase of Ordinary Shares 
          -------------------------------  ---------------------------------- 
 c)        Price(s) and volume(s)           Volume - 657,686 
                                             Price - 3.8 pence 
          -------------------------------  ---------------------------------- 
 d)        Aggregated information:          See 4c) above 
          -------------------------------  ---------------------------------- 
 e)        Date of the transaction          24 August 2018 
          -------------------------------  ---------------------------------- 
 f)        Place of the transaction         London Stock Exchange, AIM Market 
                                             (XLON) 
          -------------------------------  ---------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHKMGZRGDVGRZM

(END) Dow Jones Newswires

August 24, 2018 07:01 ET (11:01 GMT)

1 Year Byotrol Chart

1 Year Byotrol Chart

1 Month Byotrol Chart

1 Month Byotrol Chart

Your Recent History

Delayed Upgrade Clock